AAO-HNS Leads Coalition Efforts to Submit Letter to CGS Administrators Proposed Local Coverage Determination (LCD) – Botulinum Toxin Injections

Following coalition advocacy by the Academy, the American Laryngological Association (ALA) and the American Broncho-Esophagological Association (ABEA) a joint letter was submitted to CMS’ Medicare Administrative Contractor (MAC) CGS Administrators LLC’s addressing their Proposed Local Coverage Determination (LCD) – Botulinum Toxin Injections (DL 39857).  The Proposed LCD intends to address the off-label uses of Botulinum Toxins in the Medicare population. However, the Proposed LCD as written, inappropriately limits otolaryngologist-head and neck surgeons from giving “best care” treatment options to our patients.